From a cross of a Bagg albino female and a DBA male by Strong in 1920. The CBA strain was selected for a low mammary tumour incidence. Transferred via The Jackson Laboratory to Haldane and Gruneberg in 1932. To Carter (CBA/Ca) in 1947. VAF/Plus breed stock to Charles River Laboratories UK from Glaxo in 1992.
H-1a, H-2k, H-3
Research applications include brain development, neurochemistry and behavioural studies
For more information about CBA mice, please contact us at email@example.com.
Health Report for Animal Colonies in UK
Download Price List »
We offer various surgical procedures, including neurological operations, performed by our surgeons.
Our Pre-ID™ services enable you to receive animal models that have been identified with the codes you provide us.
We provide biospecimens for helping to better understand your compound’s pharmacokinetic properties.